- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 229/00 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton
Patent holdings for IPC class C07C 229/00
Total number of patents in this class: 287
10-year publication summary
|
15
|
14
|
5
|
9
|
3
|
5
|
7
|
9
|
3
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme Corp. | 2191 |
7 |
| Takeda Pharmaceutical Company Limited | 2706 |
6 |
| Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences | 113 |
5 |
| Pfizer Inc. | 3375 |
4 |
| Arkema France | 4168 |
4 |
| Bezwada Biomedical, LLC | 45 |
4 |
| Milestone Pharmaceuticals Inc. | 22 |
4 |
| Orbus Therapeutics, Inc. | 15 |
4 |
| Merck Sharp & Dohme LLC | 3757 |
4 |
| Pharma Cinq, LLC | 58 |
4 |
| APR Applied Pharma Research SA | 65 |
3 |
| Cellixbio Private Limited | 155 |
3 |
| Chugai Seiyaku Kabushiki Kaisha | 1368 |
3 |
| Emory University | 1635 |
3 |
| Green Products & Technologies, L.L.C. | 38 |
3 |
| Xgene Pharmaceutical Inc. | 11 |
3 |
| Novo Nordisk A/S | 2280 |
3 |
| Sanofi | 4093 |
3 |
| Bristol-myers Squibb Company | 4855 |
2 |
| Glaxosmithkline LLC | 535 |
2 |
| Other owners | 213 |